4//SEC Filing
Hernandez Joseph 4
Accession 0001213900-22-021910
CIK 0001817944other
Filed
Apr 26, 8:00 PM ET
Accepted
Apr 27, 4:09 PM ET
Size
10.7 KB
Accession
0001213900-22-021910
Insider Transaction Report
Form 4
Hernandez Joseph
Director
Transactions
- Other
Common Stock
2022-04-25+1,237,500→ 1,241,344 total - Other
Common Stock
2022-04-25−65,000→ 1,237,500 total(indirect: see footnote) - Award
Warrants
2022-04-25$1.00/sh+3,445,000$3,445,000→ 3,445,000 totalExercise: $11.50From: 2021-09-09Exp: 2026-09-09→ Common Stock (3,445,000 underlying)
Footnotes (5)
- [F1]Represents the transfer of an aggregate of 65,000 shares of common stock held by Blue Water Sponsor LLC (the "Sponsor") to certain affiliates of the Sponsor pursuant to certain share transfer agreements by and between the Sponsor and each transferee.
- [F2]Mr. Joseph Hernandez, a director and former chief executive officer of the registrant, is the managing member of the Sponsor. Accordingly, Mr. Hernandez may be deemed to have beneficial ownership of such shares. Mr. Hernandez disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly.
- [F3]Represents the transfer of an aggregate of 1,237,500 shares of common stock and 3,445,000 warrants held by the Sponsor to Mr. Hernandez, pursuant to that certain share transfer agreement entered by and between the Sponsor and Mr. Hernandez. Mr. Hernandez will be the holder of record of these securities after the transfer.
- [F4]Represents shares of common stock held directly by Mr. Hernandez, including (1) 1,237,500 shares of common stock transferred from the Sponsor and (2) 3,844 shares of common stock underlying the Restricted Stock Unit granted to Mr. Hernandez under the Issuer's 2021 Stock Option and Incentive Plan (the "2021 Plan") on 12/12/2021, which vests in equal annual installments over three years from the date of grant subject to the Reporting Person having a service relationship as of each such vesting date.
- [F5]The Sponsor acquired these warrants for a purchase price of $1.00 per warrant in connection with the initial public offering of the registrant. The warrants became eligible for exercise upon consummation of the registrant's initial business combination on September 9, 2021. Each whole warrant is exercisable to purchase one share of the registrant's common stock at an exercise price of $11.50.
Documents
Issuer
Clarus Therapeutics Holdings, Inc.
CIK 0001817944
Entity typeother
Related Parties
1- filerCIK 0001598384
Filing Metadata
- Form type
- 4
- Filed
- Apr 26, 8:00 PM ET
- Accepted
- Apr 27, 4:09 PM ET
- Size
- 10.7 KB